Quality Life Services - Apollo | |
151 Goodview Drive, Apollo, Pennsylvania 15613 | |
(412) 727-3451 | |
Name | Quality Life Services - Apollo |
---|---|
Location | 151 Goodview Drive, Apollo, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 177 |
Occupancy Rate | 61.02% |
Medicare ID (CCN) | 395371 |
Legal Business Name | West Haven Manor, Lp |
Ownership Type | For Profit - Partnership |
NPI Number | 1700875382 |
Organization Name | WEST HAVEN MANOR, LP |
Address | 151 Goodview Drive, Apollo, PA 15613 |
Phone Number | 724-727-3451 |
News Archive
According to the National Institutes of Health, Alzheimer's disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely.
With the U.N. Human Rights Council's June session coming up, governments have a "chance to prove that they value women's lives by taking concrete action" to recognize "preventable maternal death as a violation of women's rights," Mary Robinson and Alicia Yamin, advisory council members of the International Initiative on Maternal Mortality and Human Rights, write in a Boston Globe opinion piece.
EDMA, the European Diagnostic Manufacturers Association, enlarges its membership with six new companies: BioSystems SA, Diagnostica Stago, Innogenetics, Luminex Corporation, Orion Diagnostica and Tecan, and the Foundation for Innovative New Diagnostics (FIND).
Merck & Co., Inc. announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.
› Verified 3 days ago
NPI Number | 1962277822 |
Organization Name | QUALITY LIFE SERVICES - APOLLO, LLC |
Doing Business As | QUALITY LIFE SERVICES - APOLLO |
Address | 151 Goodview Dr, Apollo, PA 15613 |
Phone Number | 724-727-3451 |
News Archive
According to the National Institutes of Health, Alzheimer's disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely.
With the U.N. Human Rights Council's June session coming up, governments have a "chance to prove that they value women's lives by taking concrete action" to recognize "preventable maternal death as a violation of women's rights," Mary Robinson and Alicia Yamin, advisory council members of the International Initiative on Maternal Mortality and Human Rights, write in a Boston Globe opinion piece.
EDMA, the European Diagnostic Manufacturers Association, enlarges its membership with six new companies: BioSystems SA, Diagnostica Stago, Innogenetics, Luminex Corporation, Orion Diagnostica and Tecan, and the Foundation for Innovative New Diagnostics (FIND).
Merck & Co., Inc. announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
According to the National Institutes of Health, Alzheimer's disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely.
With the U.N. Human Rights Council's June session coming up, governments have a "chance to prove that they value women's lives by taking concrete action" to recognize "preventable maternal death as a violation of women's rights," Mary Robinson and Alicia Yamin, advisory council members of the International Initiative on Maternal Mortality and Human Rights, write in a Boston Globe opinion piece.
EDMA, the European Diagnostic Manufacturers Association, enlarges its membership with six new companies: BioSystems SA, Diagnostica Stago, Innogenetics, Luminex Corporation, Orion Diagnostica and Tecan, and the Foundation for Innovative New Diagnostics (FIND).
Merck & Co., Inc. announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $71799 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 12.02 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.29 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 72.63 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.73 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.56 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.22 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.08 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.57 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 19.66 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.53 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.04 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 13.1 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.15 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 4.65 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.18 | 95.98 |
Percentage of short-stay residents who made improvements in function | 87.01 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 66.86 | 82.93 |
News Archive
According to the National Institutes of Health, Alzheimer's disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely.
With the U.N. Human Rights Council's June session coming up, governments have a "chance to prove that they value women's lives by taking concrete action" to recognize "preventable maternal death as a violation of women's rights," Mary Robinson and Alicia Yamin, advisory council members of the International Initiative on Maternal Mortality and Human Rights, write in a Boston Globe opinion piece.
EDMA, the European Diagnostic Manufacturers Association, enlarges its membership with six new companies: BioSystems SA, Diagnostica Stago, Innogenetics, Luminex Corporation, Orion Diagnostica and Tecan, and the Foundation for Innovative New Diagnostics (FIND).
Merck & Co., Inc. announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.
› Verified 3 days ago
Quality Life Services - Apollo Location: 151 Goodview Drive, Apollo, Pennsylvania 15613 Phone: (412) 727-3451 |